American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy

Saved in:

Bibliographic Details
Published in:	Gastroenterology (New York, N.Y. 1943) Vol. 148; no. 1; p. 215
Main Authors:	Reddy, K Rajender, Beavers, Kimberly L, Hammond, Sarah P, Lim, Joseph K, Falck-Ytter, Yngve T
Format:	Journal Article
Language:	English
Published:	United States 01.01.2015
Subjects:	Antiviral Agents - therapeutic use Biomarkers - blood DNA, Viral - blood Hepatitis B - diagnosis Hepatitis B - drug therapy Hepatitis B - immunology Hepatitis B - prevention & control Hepatitis B - virology Hepatitis B Antibodies - blood Hepatitis B Surface Antigens - blood Hepatitis B virus - drug effects Hepatitis B virus - genetics Hepatitis B virus - immunology Hepatitis B virus - pathogenicity Humans Immunosuppressive Agents - adverse effects Recurrence Treatment Outcome Viral Load Virus Activation - drug effects
ISSN:	1528-0012, 1528-0012
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Instructional Material/Guideline-3 ObjectType-Review-4 content type line 23
ISSN:	1528-0012 1528-0012
DOI:	10.1053/j.gastro.2014.10.039